20/20 BIOLABS, INC. (AIDX) Return on equity
20/20 BIOLABS, INC. (AIDX) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-368.8%FY2024
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -368.8% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More AIDX financial trends
AIDX RevenueAIDX Net incomeAIDX Net marginAIDX Gross profitAIDX Gross marginAIDX Operating incomeAIDX Operating marginAIDX Operating cash flowAIDX Free cash flowAIDX Capital expendituresAIDX Stock buybacksAIDX Dividends paidAIDX Total assetsAIDX Total liabilitiesAIDX Shareholders’ equityAIDX overview →